# DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE
> **NDA218038** · New Drug Application · Sponsor: HQ SPCLT PHARMA · Approved 2025-02-21
## Drug
- **FDA Application Number:** NDA218038
- **Application type:** New Drug Application
- **Brand name:** DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE
- **Generic name:** DILTIAZEM HYDROCHLORIDE
- **Active ingredients:** DILTIAZEM HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** HQ SPCLT PHARMA
- **Manufacturer:** WG Critical Care, LLC
- **First approval:** 2025-02-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218038)
---
*MORVS · CC0 1.0*